microbiome research News
-
Symberix CEO Presents at Translational Microbiome Conference
Dr. Ward Peterson delivered a presentation entitled “When Good Bugs Do Bad Things: Targeting the Microbiome to Make Better Human Genome-Targeted Drugs” at the annual Translational Microbiome Conference on May 14, 2015 in Boston. The Conference focused on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make ...
-
Visionary in microbiome research
Not visible to the naked eye, but nevertheless present almost everywhere: the microbiome is the community of microscopically small bacteria, primordial bacteria, algae and fungi. This field of research is developing from a niche to mainstream and Prof. Gabriele Berg has played a significant role in this rapid development. Her research focuses on the analysis of microbial functions in plants, ...
-
Microviable Therapeutics to enter into a contractual agreement with BCD Bioscience
Microviable Therapeutics SL (Gijón, Asturias, Spain), announced a contractual agreement with BCD Bioscience Inc. (California, USA) to work on microbial fermentation and novel prebiotics to modulate the human gut microbiome. Microviable expertise on gut microbiome research will enable to conveniently process microbiota samples for fermentation applications that coupled with BCD ...
-
Intus Bio Announces New Distribution Partnership with BioCat GmbH to Accelerate Microbiome Research in Germany, Austria and Switzerland
Intus Bios, a microbiome research company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into an exclusive distribution partnership with BioCat GmbH, a leading provider of life sciences solutions, for the promotion, sale and support of all Intus Biosciences products and software in Germany, Austria, and Switzerland. Founded in ...
-
Intus Bio Announces New Canadian Distribution Partnership with D-Mark Biosciences to Accelerate Microbiome Research
Intus Biosciences, a microbiome research company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a distribution partnership for the promotion, sale and support of all Intus Biosciences products and software in Canada. “Canada is experiencing significant growth in microbiome research,” said Duane Mendis, General ...
-
Intus Bio’s management system certified to ISO 9001
Intus Bio, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, has been awarded ISO 9001:2015 certification. The company received the certificate for its management system on Nov. 4, 2020. It recognizes Intus Bio’s commitment to quality through an effective quality management system. ISO 9001:2015 is a standard issued by ...
-
Intus Bio’s Partners with Inqaba Biotechnical Industries to Accelerate Microbiome Research in Sub-Saharan Africa
Intus Bio, a microbiome research company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a partnership with Inqaba Biotechnical Industries (Pty) Ltd for product distribution and StrainID™ services in Sub-Saharan Africa. Inqaba Biotechnical Industries (Pty) Ltd, trading as inqaba biotec™, is a unique South African ...
-
Husker scientists studying our ‘second brain’ - the gut microbiome
Using what they’ve learned in the laboratory, and the specialized strains of bacteria they developed, Benson and Hutkins, along with Nebraska animal scientist Tom Burkey and former Husker scientist Jens Walter, launched their own company to bring their research to the marketplace. Synbiotic Health will provide something novel and clinically proven — a product that mixes beneficial ...
-
Intus Bio Granted Foundational Patent for High Resolution Microbiome Analysis Technology
Intus Biosciences, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, was recently awarded a new patent by the United States Patent and Trademark Office. The patent, U.S. Patent 10,894,990, was awarded January 19, 2021, for a “High Throughput Method For Identification and Sequencing of Unknown Microbial and Eukaryotic ...
-
Intus Bio Granted Patent for Cell Lysis and Preparation of High Molecular Weight DNA from Modified Cells
Intus Bio, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, was recently awarded a new patent by the United States Patent and Trademark Office for “Methods for Cell Lysis and Preparation of High Molecular Weight DNA from Modified Cells.” U.S. Patent 11,149,246 B2 was awarded October 19, 2021. The patent outlines ...
-
Intus Bio’s Software Update Enables High-throughput Microbiome Profiling of Known and Unknown Microbial Strains
Intus Biosciences, a microbiome research company with multi-platform, easy to use, ‘Sample-to-Answer’ products for characterizing microbiome populations down to the strain level, announces a significant update to its SBanalyzer software. Intus Biosciences SBanalyzer software enables discovery of never before detected species and strains from microbiome samples. In addition, ...
-
Bened Biomedical Affiliates US Distributor, Now Bened Life
Bened Biomedical Co, LTD., the global leader in psychobiotics with clinical studies, has acquired its US distributor Oryx Biomedical, Inc., who is pioneering the translation of microbiome research into impactful biotherapeutics and is one of the earliest stage companies bringing the gut-brain axis category of probiotics to the market. Based in Taiwan and founded by Prof. Ying-Chieh Tsai, PhD, ...
-
Rebiotix, Inc. and Karolinska Institutet Expand Partnership to Shape the Future of Microbiome Research
Rebiotix Inc, a Ferring Pharmaceuticals company, announced today that their Chief Scientific Officer, Dr. Ken Blount, has been appointed to Karolinska Institutet’s Joint Steering Committee (JSC) of the Centre for Translation Microbiome Research (CTMR) in Stockholm, Sweden. Dr. Blount joins two colleagues from Ferring Pharmaceuticals currently serving on the JSC – Per Falk, M.D., ...
-
Synbiotic Health Appoints Erin Vyhlidal as VP Corporate Finance
Microbiome-based ingredient company Synbiotic Health is pleased to announce the appointment of Erin Vyhlidal as Controller and Vice President, Corporate Finance. Vyhlidal is a CPA (inactive registrant) with twenty years’ experience in accounting. She previously oversaw a team of nine as VP Corporate Finance at Farmers National Company in Omaha, NE, after working at PricewaterhouseCoopers as ...
-
Microvi and Nexilico Develop Powerful Computational Platform for Gut Microbiome funded by NIH
Under a National Institute of Health (NIH) grant awarded by the National Institute of General Medical Sciences (NIGMS), Microvi, Nexilico, and their research partners have developed a first-of-its-kind predictive computational platform focused on the gut microbiome and its interaction with therapeutics. The in silico platform reduces the cost and timeframe of drug development by reducing the ...
-
Intus Bio Launches the Shoreline Breaker Instrument and HMW DNA Sample Prep Kits to Advance Microbiome Research
Intus Biosciences, a microbiome research company that develops solutions for characterizing microbiome populations down to the strain level, recently unveiled a powerful new high molecular weight (HMW) DNA prep solution supporting microbial metagenomics applications. Not all microbes are created equal: some are easy to lyse, but others can be challenging. The Shoreline BreakerTM technology is ...
-
Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service
MicrobioSeq is the microbial genomics division on behalf of CD Genomics, headquartered in New York, USA. The product manager is pleased to announce the launch of its Microbial Biomarker Discovery service, a revolutionary solution that promises to transform microbiology research. Microbiome research has rapidly gained momentum in recent years as scientists have come to appreciate the vital role ...
By CD Genomics
-
Intus Bio Launches NanoID High-Resolution Microbiome Kits and Software using Patented Long Amplicon Technology for Oxford Nanopore Systems
Intus Biosciences, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, recently unveiled a powerful new analysis solution for Oxford Nanopore Systems. Shoreline Complete NanoID is the fastest and most complete microbiome sample prep kit for long-read NGS analysis for Oxford Nanopore Systems. Leave no microbe behind from any ...
-
Synbiotic Health Welcomes Kevin Hooper as Director of Business Development
Microbiome-based ingredient company Synbiotic Health announces that Kevin Hooper has joined the company as Director of Business Development. Hooper has more than 14 years’ experience in sales and business development, most recently at the global ingredient supplier IFF Health. At Synbiotic Health he will work with Steve Prescott, Senior Vice President of Business Development, to implement ...
-
Ferring Pharmaceuticals to Present New Microbiome Research Data at IDWeek 2020
Ferring and Rebiotix, a Ferring Company, will present two oral abstracts describing translational studies of investigational microbiome-based therapeutics RBX2660 and RBX7455 for the treatment of recurrent Clostridioides difficile (C. diff) infection These data presentations strengthen the company’s leadership and scientific and clinical understanding of the two investigational ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you